Invesco NASDAQ Biotech UCITS ETF Acc
IE00BQ70R696
Invesco NASDAQ Biotech UCITS ETF Acc/ IE00BQ70R696 /
NAV2024. 06. 06. |
Vált.-0,1869 |
Hozam típusa |
Investment Focus |
Alapkezelő |
46,8507USD |
-0,40% |
Újrabefektetés |
Részvény
ETF Stocks
|
Invesco IM ▶ |
Befektetési stratégia
The objective of the Fund is to aim to track the Total Return performance of the NASDAQ Biotechnology Index (the "Index"), less fees, expenses and transaction costs. The Fund"s base currency is USD. The Index is designed to represent the performance of biotechnology and pharmaceutical securities on the NASDAQ Stock Market. The Index is a modified market capitalisation weighted index. The securities eligible for inclusion include common stocks, ordinary shares, ADRs and shares of beneficial interest or limited partnership interests. The Index has approximately 116 components and is rebalanced on a quarterly basis. Investors should note that the Index is the intellectual property of the index provider.
The Fund is a passively managed Exchange-Traded Fund. To achieve the objective the Fund will use unfunded swaps ("Swaps"). These Swaps are an agreement between the Fund and an approved counterparty to exchange one stream of cash flows against another stream but do not require the Fund to provide collateral, on the basis that the Fund has already invested in a basket of equities and equity related securities (namely shares). Please note that the Fund will purchase securities that are not contained in the Index. The performance of the Index is swapped from the counterparty to the Fund in exchange for the performance of equities and equity related securities held by the Fund.
Befektetési cél
The objective of the Fund is to aim to track the Total Return performance of the NASDAQ Biotechnology Index (the "Index"), less fees, expenses and transaction costs. The Fund"s base currency is USD. The Index is designed to represent the performance of biotechnology and pharmaceutical securities on the NASDAQ Stock Market. The Index is a modified market capitalisation weighted index. The securities eligible for inclusion include common stocks, ordinary shares, ADRs and shares of beneficial interest or limited partnership interests. The Index has approximately 116 components and is rebalanced on a quarterly basis. Investors should note that the Index is the intellectual property of the index provider.
Törzsadatok
Hozam típusa: |
Újrabefektetés |
Alapok Kategória: |
Részvény |
Ország: |
Amerikai Egyesült Államok |
Ágazat: |
ETF Stocks |
Benchmark: |
NASDAQ Biotechnology Index Total Return |
Üzleti év kezdete: |
12. 01. |
Last Distribution: |
- |
Letétkezelő bank: |
Northern Trust Fiduciary Services |
Származási hely: |
Írország |
Elosztás engedélyezése: |
Ausztria, Németország, Svájc |
Alapkezelő menedzser: |
Assenagon Asset Management S.A. |
Alap forgalma: |
344,82 mill.
USD
|
Indítás dátuma: |
2014. 11. 07. |
Befektetési fókusz: |
- |
Feltételek
Kibocsátási felár: |
0,00% |
Max. Administration Fee: |
0,40% |
Minimum befektetés: |
1,00 USD |
Deposit fees: |
- |
Visszaváltási díj: |
0,00% |
Egyszerűsített tájékoztató: |
Letöltés (Nyomtatási változat) |
Eszközök
Részvények |
|
98,92% |
Egyéb |
|
1,08% |
Országok
Amerikai Egyesült Államok |
|
80,71% |
Svájc |
|
2,97% |
Izrael |
|
2,92% |
Svédország |
|
2,65% |
Kína |
|
2,42% |
Argentina |
|
1,29% |
Írország |
|
1,24% |
Dánia |
|
1,20% |
Kanada |
|
0,94% |
Németország |
|
0,92% |
Hollandia |
|
0,69% |
Bermuda |
|
0,46% |
Finnország |
|
0,40% |
Norvégia |
|
0,10% |
Egyéb |
|
1,09% |
Ágazatok
Fogyasztói javak |
|
25,54% |
IT/Telekommunikáció |
|
20,26% |
Egészségügy |
|
18,15% |
Ipar |
|
11,86% |
Pénzügy |
|
10,53% |
Energia |
|
6,95% |
Szállító |
|
3,32% |
Árupiac |
|
2,26% |
Egyéb |
|
1,13% |